Basic studies have reported that VEGF3 inhibitors can elevate the chemical sensitization of ovarian cancer stem cells by downregulating BRCA1/2 [43], but the specific mechanism in breast cancer still needs further exploration with basic experiments. The gene discussed is BRCA1; the disease is ovarian carcinoma.